Colossal declines in the shares of Valeant Pharmaceuticals (NYSE:VRX) and Endo International (NMS:ENDP) wiped out billions of investor capital. The companies’ loose application of accounting guidelines has made the Generally Accepted Accounting Principles (GAAP) vs. non-GAAP (adjusted) debate a hot topic. Unfortunately, when issues […]
Information Arbitrage is (InfoArb) is simply one of the biggest competitive advantages investors have in their war chest to achieve out-sized portfolio returns. “An arbitrage exists when a disconnect between stock prices and available public information on a company is […]
Automated stock screeners are overrated, but on the surface they may seem attractive. With over 20,000 stocks to choose from on U.S. exchanges and the over the counter market, it is natural to want to explore ways to reduce potential investment choices […]
Big returns can come in small packages. That’s certainly the case with investing in a micro-cap, the term used to refer to a publicly-traded company with a market capitalization between $50 million and $300 million. Why should you care about […]